Expect the extraordinary in prenatal screening with VeriSeq NIPT solution
23 Jun 2026
Discover how advances in prenatal screening are redefining confidence and clarity for clinicians and expecting families. Explore the VeriSeq™ NIPT Solution v2, an in‑lab IVD workflow designed to deliver exceptional ease, accuracy, and speed. Learn about its automated, easy‑to‑use system, ≥99.9% sensitivity and specificity, and how results will be delivered in ~26 hours with only 2 hours of hands‑on time. Plus, find out how this streamlined solution can integrate seamlessly into your lab and support reliable, high‑quality screening outcomes.
About the company
Illumina
Innovative technologies
At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.
Related products
Request Quote for All Products
VeriSeq™ NIPT Solution v2
IlluminaComprehensive in-lab NIPT IVD solution including reagents, instruments, and software for accurate aneuploidy screening results in 26 hours.
